PRECISION MEDICINE
AND THE FUTURE
OF GENOMICS
PMFG SUMMIT 2025

Sedeer Medical

Established in 2001, Sedeer Medical is a Qatari total healthcare solution provider that has been at the forefront of a never-ending quest to provide the latest and the best solutions and services to its clients. Sedeer Medical has earned trust and credibility as a leading medical distributor in Qatar since its inception. Our dedication to the healthcare and scientific sectors, coupled with extensive product expertise and keen insights into market and technology trends, allows us to offer one-stop solutions tailored to our customers’ needs. As a premier medical equipment distributor, we continuously update our knowledge of new trends in the medical and scientific fields to provide the best options to our customers.
Our unbeatable presence in the market over the past 22 years has made us a powerful partner among the world’s leading scientific and healthcare brands. We represent leading brands from around the world and are partners with industry leaders. This has enabled us to maintain our position as the most preferred partner and number one solution provider in the industry.

Google Cloud

Dell Technologies

Khalid Scientific Co. W.L.L.

Khalid Scientific Co. W.L.L. was established in 1979 with a passionate desire to adequately provide medical, laboratory and pharmaceutical solutions together with services of the highest quality.

KSC is a diversified company housing ten distinct divisions – Laboratory, Imaging, Medical Equipment, Cardiology, Consumables, Healthcare Facilities, Surgical, Projects and Service under its sales and operations where each has its own specific field and scope, and functions as a team to make better care possible for patients.

Together with our leading Healthcare Providers, valued Channel Partners and Clients – KSC provides our valuable customers the ultimate innovative solutions and a wide range of medical products safely and cost-effectively.

New Concept Pharma

Mannai

Mannai ICT Networking and ELV, a subsidiary of Mannai Corporation Group Qatar, is a leading ICT solutions provider in Qatar and beyond, delivering an extensive portfolio of cutting-edge technologies and services designed to drive innovation and efficiency.

Specializing in AI-driven applications, advanced data infrastructure, cybersecurity, managed services, collaboration tools, surveillance systems, smart building technologies, and IoT integration, Mannai ICT Networking and ELV caters to the diverse needs of businesses across industries.

The company’s expertise extends to delivering tailored solutions that optimize operations, enhance security, and support digital transformation. With a strong focus on cybersecurity, Mannai ICT Networking and ELV provides state-of-the-art solutions to safeguard digital assets, ensuring robust protection against evolving threats.

Backed by strategic global partnerships and leading global ICT brands, industry-leading certifications, and a commitment to excellence, Mannai ICT Networking and ELV stands at the forefront of technology innovation.

Trusted by enterprises of all scales, Mannai ICT Networking and ELV continues to empower businesses with scalable, reliable, and future-ready solutions for a rapidly changing digital landscape.

Zetta Genomics

At Zetta Genomics our products and services are empowering the application of genomic data to improve health outcomes for millions of patients around the world.

We are pioneers in genomics with over a decade of experience – handling complex and large genomic data is at the heart of what we do. Born from the prestigious University of Cambridge and honed through our contributions to Genomics England’s landmark 100,000 Genomes Project, XetaBase leverages cutting-edge, real-world tested technology to deliver powerful genomic analysis solutions.

As a unified platform for both research and clinical applications, XetaBase enables us to collaborate with healthcare systems, life sciences companies, research institutions and global health-tech innovators, ensuring that the promise of precision medicine becomes a reality for all.

CHOP

Gold Sponsor / Knowledge Partner

Children's Hospital of Philadelphia (CHOP) is the first hospital in the United States devoted exclusively to the care of children. Since its start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic “firsts” in pediatric medicine.  Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives, worldwide.

World-class Care

Our physicians are internationally recognized experts in every pediatric specialty, including precision medicine, genomics, oncology/hematology, cardiac care, fetal medicine, orthopedics, neonatology, endocrinology, gastroenterology and urology.  Children’s Hospital is also consistently recognized as a national leader in the advancement of healthcare for children:  for the 17^th straight year, U.S. News & World Report ranked CHOP among the best children’s hospitals in the United States.

U.S. News also ranked the Department of Pediatrics at the University of Pennsylvania’s Perelman School of Medicine, located at CHOP, as the No. 1 Department of Pediatrics in the country by U.S. News for the last 11 years.

Innovation and education

A critical part of CHOP’s mission to be the leader in advancing healthcare for children globally is the ability to robustly integrate novel research into the high-quality clinical care it delivers.  Celebrating its 100^th anniversary in 2022, Children's Hospital of Philadelphia Research Institute is one of the largest pediatric research programs in the United States with nearly $350 million in total grant funding, and over 1000 principal investigators (with active grants/protocols).

Eastgate Medical Service

Eastgate Medical Services, a customer-centric distributor of medical devices and pharmaceuticals, Eastgate Medical Services is committed to supplying top-tier brands and products.

Through strategic partnerships and a focus on long-term relationships, we aim to lead the industry by delivering exceptional value to our clients.

Our goal is simple: to ensure customer satisfaction by offering the best for the Patient in terms competitive pricing, superior quality, and mutual growth opportunities.

CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for patients. With headquarters in Rostock, Germany, and further operations in Berlin, Germany as well as Cambridge, Massachusetts, USA, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families.

CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics.

Eastgate Medical Services, a customer-centric distributor of medical devices and pharmaceuticals, partners with CENTOGENE, a rare disease company dedicated to transforming genetic data into medical solutions. Together, we offer innovative solution and personalized care, ensuring superior outcomes for for patients with rare diseases and their families.

Centogene

Al Suwaidi Trading EST

Since 1982, Mr. Ali Al Suwaidi, founder and Chairman of Ali Al Suwaidi Trading Establishment "ASTE", has dedicated himself to enhancing Qatar’s healthcare sector. Over the past 42 years, ASTE has built a strong reputation for the reliable distribution of high-quality medical, laboratory, and pharmaceutical products, each aligning with stringent quality standards.

Today, Ali Al Suwaidi Trading "AST" enters an exciting new chapter with a rebranding, introducing a new logo that symbolizes our enduring commitment. With this, we are also proud to welcome our new CEO, Mrs. Shaikha Ali Al-Suwaidi who will continue her father’s legacy under his guidance. Mrs. Sheikha brings with herself a personal mission, ensuring the refinement of operations and procedures, while staying true to the legacy her father has instilled in the company for decades past.

We remain committed to serving healthcare providers, laboratories, and pharmacies with precision, reliability, and care as a trusted partner in Qatar, with patient well-being as our first priority.

GenQA

GenQA - Genomic Quality Assessment, is an ISO17043-2023 accredited global EQA provider offering a wide repertoire of EQAs/Proficiency Testing (PT) ) to laboratories and clinicians world-wide to meet their quality and accreditation needs and ensure high quality end to end genomic services. Areas covered include Genomic and Inherited Disorders, PGT, Reproductive Genetics (including NIPT), NGS, Molecular Newborn Screening, Haematological Neoplasms, Molecular Pathology, Sample Handling, DNA extractions, Clinical Genetics/Genetic Counselling. GenQA also offers competency assessments for individuals through our educational platform, GENie focussing on classification of variants and ISCN/HGVS nomenclature.

SeqOne

SeqOne is a leading European provider of AI-powered software for next-generation sequencing (NGS) data analysis in oncology and rare diseases. Its cloud-based platform transforms complex genomic data into fast, precise, and actionable insights, supporting molecular labs in delivering life-saving diagnoses and treatments. The SeqOne Platform is CE-IVD Class C certified under IVDR as an in vitro diagnostic medical device. Driven by the vision of personalized medicine for every patient, everywhere, SeqOne is scaling the future of genomic medicine—one lab at a time.

Cytomate Solutions and Services

Established in Doha, Qatar, Cytomate has rapidly risen as a beacon of innovation in cybersecurity, showcasing its global competitiveness and its distinctive Qatari identity. The company’s birth emerged from a recognition of the increasing complexities of cyber threats and a profound determination to counteract them. The invaluable support and investment from Qatar Development Bank have been instrumental in propelling Cytomate to the forefront of its industry. The company now proudly stands as the only Qatari entity providing the Breach and Attack Simulation (BAS) solution, a cutting-edge tool empowered by Artificial Intelligence (AI), specifically SnipeX.

StraalPharma B.V.

Founded in 2018 in the Netherlands, StraalPharma B.V. specializes in addressing medication shortages for hospitals. We source from reputable companies across the globe, including the USA, UK, Europe, Turkey, Switzerland, Australia, Canada, and more, to provide hospitals with the medications they need.

Our approach is focused on meeting specific demands rather than maintaining a standard product list, ensuring we're responsive to the immediate needs of healthcare providers.

We adhere to strict storage and transportation standards, holding WDA and GDP licenses that are published on Eudra GMDP for quality assurance.

Gulf Scientific Corporation

Founded in 1990, Gulf Scientific Corporation (GSC) is headquartered in Dubai, United Arab Emirates with four regional offices and a number of distribution outlets across the Middle East.

GSC has established strategic partnerships with market leaders that include Merck, Thermo Fisher Scientific, DNA Script, and Waters among others to ensure that clients have the best available resources to meet their critical laboratory needs.

With an unrivaled support structure that includes manufacturer-certified service and training centers, GSC is the preferred choice for companies in a wide range of industries including, clinical, pharmaceutical, food and beverage, oil and gas, environmental, and others.

GOSH

Great Ormond Street Hospital for Children

CHOP

Gold Sponsor / Knowledge Partner

Children's Hospital of Philadelphia (CHOP) is the first hospital in the United States devoted exclusively to the care of children. Since its start in 1855, CHOP has been the birthplace for countless breakthroughs and dramatic “firsts” in pediatric medicine.  Built on a foundation of delivering safe, high-quality, family-centered care, the Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives, worldwide.

World-class Care

Our physicians are internationally recognized experts in every pediatric specialty, including precision medicine, genomics, oncology/hematology, cardiac care, fetal medicine, orthopedics, neonatology, endocrinology, gastroenterology and urology.  Children’s Hospital is also consistently recognized as a national leader in the advancement of healthcare for children:  for the 17^th straight year, U.S. News & World Report ranked CHOP among the best children’s hospitals in the United States.

U.S. News also ranked the Department of Pediatrics at the University of Pennsylvania’s Perelman School of Medicine, located at CHOP, as the No. 1 Department of Pediatrics in the country by U.S. News for the last 11 years.

Innovation and education

A critical part of CHOP’s mission to be the leader in advancing healthcare for children globally is the ability to robustly integrate novel research into the high-quality clinical care it delivers.  Celebrating its 100^th anniversary in 2022, Children's Hospital of Philadelphia Research Institute is one of the largest pediatric research programs in the United States with nearly $350 million in total grant funding, and over 1000 principal investigators (with active grants/protocols).